23 May 2013
Keywords: PDL BioPharma, Roche, Genentech, Royalties, Law suit, Nevada judge
Article | 12 July 2011
The Second Judicial District Court of US state Nevada ruled in favor of PD BioPharma (Nasdaq: PDLI) on two motions ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 July 2011
11 July 2011
© 2013 thepharmaletter.com